Yang Xiang to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Yang Xiang has written about Randomized Controlled Trials as Topic.
Connection Strength
0.221
-
Xiang Y, Yang S, Guo L, Dong C, Majoie CBLM, Siddiqui AH, Mocco J, Cavalcante F, Li BH, Wang JH, Huang B, Wang DZ, Yu NW, Schonewille WJ, Turk AS, Guo FQ. BEST-BAO: a multicentre, prospective, randomised controlled trial of endovascular treatment with or without intravenous thrombolysis in acute ischaemic stroke due to basilar artery occlusion - study protocol and rationale. Stroke Vasc Neurol. 2026 Jun 29; 11(3):358-364.
Score: 0.183
-
Jiang F, Mao MY, Xiang Y, Lu X, Guan CL, Jiao LZ, Wan XR, Feng FZ, Ren T, Yang JJ, Zhao J. Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0-4): study protocol for a prospective, multicentre, randomized trial. BMC Cancer. 2023 Aug 23; 23(1):784.
Score: 0.038